what's a maintenance dose of tirzepatide Dosing for Weight Loss in Units Tirzepatide dosage chart for weight

Drug Interactions: Risk of hypoglycemia when used with Insulin or sulfonylureas

Learn how they work, what to expect, and key tips for safety, success, and sustainable results before getting started.

Discover all five new Zero Sugar yerba mate flavors from Mateina in one refreshing sampler

These findings align with results from the SURMOUNT-5 trial and an earlier real-world study from Truveta Research, with similar patterns observed across different study designs and patient populations

Reliable shipping to USA, UK, and UAE.

Seventy-two week outcomes from the SURMOUNT-5 clinical trial have shown that tirzepatide (Zepbound) met the primary endpoint and all five key secondary endpoints, demonstrating superiority, compared to semaglutide (Wegovy) across the trial.The detailed results were presented at the 32nd European Congress on Obesity (ECO) and simultaneously published in The New England Journal of Medicine.SURMOUNT-5 was a 72-week, multi-centre, randomised, open-label, Phase 3b trial evaluating the efficacy and